Jefferies highlights Bilibili's (BILI) focus on young users, AI-driven content, gaming longevity, and ad market gains.

Pearl Abyss stock surges as Crimson Desert release nears, targets 540 billion won revenue Pearl Abyss shares rally as ...

Bernstein started coverage of Kuaishou Technology and Bilibili Inc (NASDAQ:BILI). with Outperform ratings, arguing both Chinese online‑video operators are set to capture a larger share of digital ...

Bilibili rallied for a second day on Monday, adding 7.66 percent to close at $22.48 apiece following news that it was set to ...

Bilibili's valuation continues to be attractive and doesn't reflect current market consensus. Read why I'm upgrading my ...

Bernstein initiated coverage of Bilibili (BILI) with an Outperform rating and $28 price target The company offers a compelling way to play the secular themes of the online video market, the analyst ...

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals' Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...

DLHC meets this criterion too, as the stock gained 36.4% over the past 12 weeks. Moreover, the momentum for DLHC is fast paced, as the stock currently has a beta of 1.33.